Dr. Holmes and Dr. Holloway have been working hard to develop a cure for the Covid-19 virus using a similar approach to their research on Sickle Cell disease, a condition that similarly disproportionately affects Black and Brown people worldwide. Sickle Cell disease affects just over 100,000 people in the United States, nearly 95% of whom are Black. Sickle Cell disease afflicts sufferers with extreme pain attacks that happen without warning and can shorten a person’s life span by 36%.Across the United States with a total population of approximately 328,238,413 people, these negative health conditions have hit Black and Brown people the most. Recent studies show that aggregated deaths from COVID-19 across 40 states and the District of Columbia have reached new highs for all groups, with Black people affected the most severely:• 1 in 1,625 Black Americans has died (or 61.5 deaths per 100,000)• 1 in 3,500 Latino Americans has died (or 28.6 deaths per 100,000)• 1 in 3,200 Asian Americans has died (or 31.25 deaths per 100,000)• 1 in 3,600 White Americans has died (or 27.8 deaths per 100,000)Professor Renaud and Dr. Moore conducted a series of experimental trials with a new Sickle Cell vaccine they created where they hypothesized that the sickle cells would begin to turn back to normal after 12 hours, though they were not sure how fast all the cells would return to their normal circular shape.Below is an outline of the data they collected from five different experiments: